|
Consensus
Proposals for a Unified System of Nomenclature of Hepatitis
C Virus Genotypes in the Future
International
standardization and coordination of the nomenclature of variants
of hepatitis C virus (HCV) is increasingly needed as more
is discovered about the scale of HCV-related liver disease
and important biological and antigenic differences that exist
between variants.
A
group of scientists expert in the field of HCV genetic variability,
and those involved in development of HCV sequence databases,
the Hepatitis Virus Database (Japan), euHCVdb (France), and
Los Alamos (United States), met to re-examine the status of
HCV
genotype nomenclature, resolve conflicting
genotype or subtype names among described
variants of HCV, and draw up revised criteria for the assignment
of new genotypes as they are discovered in the future.
A
comprehensive listing of all currently classified variants
of HCV incorporates a number of agreed genotype and subtype
name reassignments to create consistency in nomenclature.
The
paper also contains consensus proposals for the classification
of new variants into genotypes and subtypes, which recognizes
and incorporates new knowledge of HCV genetic diversity and
epidemiology.
A
proposal was made that HCV variants be
classified into 6 genotypes
(representing the 6 genetic groups defined by phylogenetic
analysis).
Subtype
name assignment will be either confirmed or provisional, depending
on the availability of complete or partial nucleotide sequence
data, or remain unassigned where fewer than 3 examples of
a new subtype have been described.
The
authors conclude, “These proposals provide the framework by
which the HCV databases store and provide access to data on
HCV, which will internationally coordinate the assignment
of new genotypes and subtypes in the future.”
Table
1. Confirmed HCV Genotypes/Subtypes
Table
2. Listing of HCV Variants With Proposed
Changes
in Genotype
Nomenclature
Table
3. Provisionally Assigned HCV
Subtypes
09/30/05
Reference
P
Simmonds and others. Consensus proposals for a unified system
of nomenclature of hepatitis C virus genotypes. Hepatology
42(4): 962-973.
|
Table 1. Confirmed HCV
Genotypes/Subtypes
|
|
|
|
Genotype*
|
Locus/Isolate(s)
|
Accession number(s)
|
Reference(s)
|
|
|
|
Genotype 1
|
|
|
|
|
1a
|
HPCPLYPRE, HPCCGAA
|
M62321, M67463
|
[67],[68]
|
|
1b
|
HPCJCG, HPCHUMR
|
D90208, M58335
|
[69],[70]
|
|
1c
|
HPCCGS, AY051292
|
D14853, AY051292
|
[71]
|
|
Genotype 2
|
|
|
|
|
2a
|
HPCPOLP, JFH-1
|
D00944, AB047639
|
[72],[73]
|
|
2b
|
HPCJ8G, JPUT971017
|
D10988, AB030907
|
[9],[74]
|
|
2c
|
BEBE1
|
D50409
|
[75]
|
|
2k
|
VAT96
|
AB031663
|
[58]
|
|
Genotype 3
|
|
|
|
|
3a
|
HPCEGS, HPCK3A
|
D17763, D28917
|
[76],[77]
|
|
3b
|
HPCFG
|
D49374
|
[78]
|
|
3k
|
HPCJK049E1
|
D63821
|
[59]
|
|
Genotype 4
|
|
|
|
|
4a
|
HCV4APOLY
|
Y11604
|
[79]
|
|
Genotype 5
|
|
|
|
|
5a
|
EUH1480, SA13
|
Y13184, AF064490
|
[80],[81]
|
|
Genotype 6
|
|
|
|
|
6a
|
HCV12083, 6a33
|
Y12083, AY858526
|
[82]
|
|
6b
|
Th580
|
D84262
|
[83]
|
|
6d
|
VN235
|
D84263
|
[83]
|
|
6g
|
HPCJK046E2
|
D63822
|
[59]
|
|
6h
|
VN004
|
D84265
|
[83]
|
|
6k
|
VN405
|
D84264
|
[83]
|
|
|
|
|
NOTE. Tables 1, 2, and 3 were compiled by a working group of Donald
Murphy, Erwin Sablon, and Phillipe Halfon.
* Consensus
proposed genotype/subtype names. For instances in
which multiple sequences of a HCV genotype are available,
two sequences have been listed, prioritized by (1)
publication date, or (2) submission date when unpublished.
Locus (or
isolate name, if locus is the same as the accession
number).
Sequence
obtained from acute phase plasma of a chimpanzee experimentally
infected with (human-derived) isolate SA13.
Simmonds et al. Hepatology 42(4). October 2005.
|
|
Table 2. Listing of HCV
Variants With Proposed Changes in Genotype Nomenclature
|
|
|
|
Proposed Designation*
|
Published Designation
|
Status
|
Isolate
|
Region Sequenced§
|
Reference(s)
|
|
|
|
Genotype 2
|
|
|
|
|
|
|
2k
|
2j
|
C
|
RU169
|
NS5B (D86532), 3 UTR (D86532)
|
[83]
|
|
2j
|
2l
|
P
|
BA047
|
NS5B (D86530), 3 UTR (D86530)
|
[83]
|
|
2n
|
2e
|
P
|
NL50
|
C/E1 (L39309), NS5B (L44602)
|
[84]
|
|
2o
|
4f/2f
|
P
|
FR4
|
C/E1 (L38333), NS5B (L38373)
|
[84]
|
|
2p
|
2f
|
P
|
NL33
|
C/E1, (L39300), BS5B (L44601)
|
[84]
|
|
2q
|
2k
|
P
|
BA045
|
NS5B (D86529), 3 UTR (D86529)
|
[83]
|
|
Genotype 3
|
|
|
|
|
|
|
3k
|
10a
|
C
|
HPCJK049E1
|
Complete genome (D63821)
|
[59]
|
|
Genotype 4
|
|
|
|
|
|
|
4r
|
4a
|
P
|
Z4
|
C/E1 (U10236/L16652)
|
[12],[64]
|
|
|
|
|
FrSSD120
|
C/E1 (AJ401097), NS5B (AJ291282)
|
[93]
|
|
4n
|
4 alfa
|
P
|
1359
|
C/E1 (AF271874)
|
[65]
|
|
4o
|
4 beta
|
P
|
2153
|
C/E1 (AF271882), NS5B (AF271815)
|
[65]
|
|
Genotype 6
|
|
|
|
|
|
|
6c
|
7d
|
P
|
Th846
|
C/E1 (D37843), NS5B (D37857)
|
[35]
|
|
6d
|
7b
|
C
|
VN235
|
Complete genome (D84263)
|
[83]
|
|
6e
|
7a
|
P
|
VN540
|
C/E1 (D88474), NS5B (D87361)
|
[34]
|
|
6f
|
7e
|
P
|
BB7
|
NS5B (D28541)
|
[96]
|
|
6f
|
7c
|
P
|
Th271
|
C/E1 (D37844), NS5B (D37858)
|
[35]
|
|
6g
|
11a
|
C
|
HPCJK046E
|
Complete genome (D63822)
|
[59]
|
|
6h
|
9a
|
C
|
VN004
|
Complete genome (D84265)
|
[83]
|
|
6i
|
9b
|
P
|
Th555
|
C/E1 (D37849), NS5B (D37863)
|
[35]
|
|
6j
|
9c
|
P
|
Th553
|
C/E1 (D37848), NS5B (D37862)
|
[35]
|
|
6k
|
8b
|
C
|
VN405
|
Complete genome (D84264)
|
[34]
|
|
6l
|
8a
|
P
|
VN507
|
C/E1 (D88470), NS5B (D87357)
|
[34]
|
|
|
|
|
* Proposed
new name based on revised criteria for genotype designations.
Classification
status; C: Confirmed; P: Provisional.
Example
of isolates referred to in associated publications
(last column).
§ Regions
sequenced (accession numbers in parentheses), prioritized
for (1) complete genome; (2) Core/E1 and NS5B regions;
(3) other regions where core/E1 and NS5B regions are
not both available.
Simmonds et al. Hepatology 42(4). October 2005
|
|
|
|
Table 3. Provisionally
Assigned HCV Subtypes
|
|
|
|
|
Isolate
|
Accession Number(s)*
|
Reference(s)
|
|
Core/E1
|
NS5B
|
|
|
|
Genotype 1
|
|
|
|
|
|
1d
|
HC1-N15, HC1-N16
|
L39299, L39302
|
L38377, L38372
|
[84]
|
|
1e
|
CAM1078, QC248
|
L38349(C), AY894555
|
L38361, AY894553
|
[62],[84]
|
|
1f
|
FR2
|
L38350
|
L38371
|
[84]
|
|
1g
|
2152, 1382
|
AF271822, AF271820
|
AF271798, AF271797
|
[65]
|
|
1h
|
98CM1521, QC94
|
AY256790(C), AY434131
|
AY257087, AY434132
|
[32],[62]
|
|
1i
|
FR16, QC77
|
n.a., AY434119
|
L48495, AY434120
|
[62],[85]
|
|
1j
|
QC2, QC89
|
AY434158, AY434128
|
AY434106, AY434129
|
[62]
|
|
1k
|
QC68, QC82
|
AY434112, AY434122
|
AY434113, AY434123
|
[62]
|
|
1l
|
98CM1383, 98CM1427
|
AY256789(C), AY256792(C)
|
AY257083, AY257091
|
[32]
|
|
Genotype 2
|
|
|
|
|
|
2d
|
NE92, BN177
|
L39294, n.a.
|
L29634, AF037244
|
[66],[86]
|
|
2e
|
JK020, JK025
|
D49745, D49746
|
D49760, D49761
|
[59]
|
|
2f
|
JK081, JK139
|
D49754, D49757
|
D49769, D49777
|
[59]
|
|
2g
|
MED017
|
n.a.
|
X93323
|
[26]
|
|
2h
|
MED007
|
n.a.
|
X93327
|
[26]
|
|
2i
|
FR13, HN4
|
n.a., X76411/X76415
|
L48492, L48499
|
[87],[88]
|
|
2j
|
BA047, QC106
|
n.a., AY894528
|
D86530, AY894526
|
[62],[83]
|
|
2l
|
FR15
| | |